136 related articles for article (PubMed ID: 17690504)
1. Clinicopathologic significance of an immunohistochemical expression of p27 in scirrhous carcinoma of the breast.
Nozoe T; Oyama T; Mori E; Uramoto H; Takenoyama M; Hanagiri T; Sugio K; Yasumoto K
Breast Cancer; 2007; 14(3):277-80. PubMed ID: 17690504
[TBL] [Abstract][Full Text] [Related]
2. Significance of basic fibroblast growth factor and fibroblast growth factor receptor protein expression in the formation of fibrotic focus in invasive ductal carcinoma of the breast.
Hasebe T; Imoto S; Ogura T; Mukai K
Jpn J Cancer Res; 1997 Sep; 88(9):877-85. PubMed ID: 9369936
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of scoring system based on histological heterogeneity of invasive ductal carcinoma for node-negative breast cancer patients.
Kurosumi M; Tabei T; Inoue K; Takei H; Ninomiya J; Naganuma R; Suemasu K; Higashi Y; Tsuchiya E
Oncol Rep; 2003; 10(4):833-7. PubMed ID: 12792731
[TBL] [Abstract][Full Text] [Related]
4. Mucin antigens expression and Ki-67 labeling in breast cancer: the peculiarity in scirrhous carcinoma.
Nomoto M; Yonezawa S; Tokunaga M; Kim YS; Sato E
Pathol Int; 1995 Mar; 45(3):233-9. PubMed ID: 7787994
[TBL] [Abstract][Full Text] [Related]
5. [Hydroxyproline in breast cancer].
Iida T
Nihon Geka Gakkai Zasshi; 1989 Jun; 90(6):914-9. PubMed ID: 2552280
[TBL] [Abstract][Full Text] [Related]
6. Loss of p27KIP1 expression in fully-staged node-negative breast cancer: association with lack of hormone receptors in T1a/b, but not T1c infiltrative ductal carcinoma.
Mirchandani D; Roses DF; Inghirami G; Zeleniuch-Jacquotte A; Cangiarella J; Guth A; Safyan RA; Formenti SC; Pagano M; Muggia F
Anticancer Res; 2011 Dec; 31(12):4401-5. PubMed ID: 22199306
[TBL] [Abstract][Full Text] [Related]
7. Ultrasound examination is useful for prediction of histologic type in invasive ductal carcinoma of the breast.
Kijima Y; Yoshinaka H; Koriyama C; Funasako Y; Natsugoe S; Aikou T
Ultrasound Med Biol; 2008 Apr; 34(4):517-24. PubMed ID: 18045769
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of c-erbB-2 expression in invasive ductal carcinoma of the breast.
Horiguchi J; Iino Y; Takei H; Morishita Y
Jpn J Clin Oncol; 1995 Aug; 25(4):119-23. PubMed ID: 7666587
[TBL] [Abstract][Full Text] [Related]
9. Cytoplasmic Skp2 expression is associated with p-Akt1 and predicts poor prognosis in human breast carcinomas.
Liu J; Wei XL; Huang WH; Chen CF; Bai JW; Zhang GJ
PLoS One; 2012; 7(12):e52675. PubMed ID: 23300741
[TBL] [Abstract][Full Text] [Related]
10. Decreased immunoreactivity for p27 protein in patients with early-stage breast carcinoma is correlated with HER-2/neu overexpression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node status: results from International Breast Cancer Study Group Trial V.
Spataro VJ; Litman H; Viale G; Maffini F; Masullo M; Golouh R; Martinez-Tello FJ; Grigolato P; Shilkin KB; Gusterson BA; Castiglione-Gertsch M; Price K; Lindtner J; Cortés-Funes H; Simoncini E; Byrne MJ; Collins J; Gelber RD; Coates AS; Goldhirsch A;
Cancer; 2003 Apr; 97(7):1591-600. PubMed ID: 12655514
[TBL] [Abstract][Full Text] [Related]
11. A study to investigate the role of p27 and cyclin E immunoexpression as a prognostic factor in early breast carcinoma.
Pillay K; McCleod H; Chetty R; Hall P
World J Surg Oncol; 2011 Mar; 9():31. PubMed ID: 21410943
[TBL] [Abstract][Full Text] [Related]
12. Allelic loss on chromosome 1p is associated with progression and lymph node metastasis of primary breast carcinoma.
Tsukamoto K; Ito N; Yoshimoto M; Kasumi F; Akiyama F; Sakamoto G; Nakamura Y; Emi M
Cancer; 1998 Jan; 82(2):317-22. PubMed ID: 9445188
[TBL] [Abstract][Full Text] [Related]
13. High expression levels of p27 correlate with lymph node status in a subset of advanced invasive breast carcinomas: relation to E-cadherin alterations, proliferative activity, and ploidy of the tumors.
Kouvaraki M; Gorgoulis VG; Rassidakis GZ; Liodis P; Markopoulos C; Gogas J; Kittas C
Cancer; 2002 May; 94(9):2454-65. PubMed ID: 12015771
[TBL] [Abstract][Full Text] [Related]
14. [Relationship of ezrin protein expression to the carcinogenesis and prognosis of infitrating breast ductal carcinoma].
Ma L; Zhang XH; Xing LX; Li YH; Wang XL; Wang YJ
Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):279-83. PubMed ID: 18788632
[TBL] [Abstract][Full Text] [Related]
15. p27(kip1) expression in breast carcinomas: an immunohistochemical study on 512 patients with long-term follow-up.
Barbareschi M; van Tinteren H; Mauri FA; Veronese S; Peterse H; Maisonneuve P; Caffo O; Scaioli M; Doglioni C; Galligioni E; Dalla Palma P; Michalides R
Int J Cancer; 2000 May; 89(3):236-41. PubMed ID: 10861499
[TBL] [Abstract][Full Text] [Related]
16. Expression of p21Waf1, p27Kip1 and cyclin D1 proteins in breast ductal carcinoma in situ: Relation with clinicopathologic characteristics and with p53 expression and estrogen receptor status.
Oh YL; Choi JS; Song SY; Ko YH; Han BK; Nam SJ; Yang JH
Pathol Int; 2001 Feb; 51(2):94-9. PubMed ID: 11169147
[TBL] [Abstract][Full Text] [Related]
17. Inactivation of PTEN is associated with a low p27Kip1 protein expression in breast carcinoma.
Tsutsui S; Inoue H; Yasuda K; Suzuki K; Tahara K; Higashi H; Era S; Mori M
Cancer; 2005 Nov; 104(10):2048-53. PubMed ID: 16208702
[TBL] [Abstract][Full Text] [Related]
18. Ultrasonographic findings of invasive lobular carcinoma differentiation of invasive lobular carcinoma from invasive ductal carcinoma by ultrasonography.
Ohta T; Tsujimoto F; Nakajima Y; Fukuda M; Takag M
Breast Cancer; 2005; 12(4):304-11. PubMed ID: 16286911
[TBL] [Abstract][Full Text] [Related]
19. Expression of mucins (MUC1, MUC2, MUC5AC and MUC6) in mucinous carcinoma of the breast: comparison with invasive ductal carcinoma.
Matsukita S; Nomoto M; Kitajima S; Tanaka S; Goto M; Irimura T; Kim YS; Sato E; Yonezawa S
Histopathology; 2003 Jan; 42(1):26-36. PubMed ID: 12493022
[TBL] [Abstract][Full Text] [Related]
20. The relationship between FDG uptake in PET scans and biological behavior in breast cancer.
Shimoda W; Hayashi M; Murakami K; Oyama T; Sunagawa M
Breast Cancer; 2007; 14(3):260-8. PubMed ID: 17690502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
